Melatonin has quietly become one of the most widely used supplements in the United States. Sales have more than doubled over the past decade, and an estimated one in four American adults reports taking it. Yet recent research is reshaping the picture in two important ways: most users are likely taking far more than they need, and the products on store shelves often contain very different amounts of the hormone than their labels claim.
The result is a supplement that can genuinely help with certain narrowly defined sleep problems, but that is frequently used in ways the evidence does not support. Here is what current research indicates about effective dose, supplement quality, and safety in both adults and children.
What melatonin actually does
Melatonin is a hormone produced by the pineal gland in response to darkness. It is not a sedative. Its primary biological role is to signal the brain and body that it is night, helping align the circadian rhythm. Endogenous melatonin levels typically begin to rise about two hours before habitual bedtime, peak in the middle of the night, and fall toward morning.
Because of this signaling role, melatonin is most useful as a chronobiotic — a substance that shifts the timing of the internal clock — rather than as a sleeping pill. Clinical guidelines from the American Academy of Sleep Medicine (AASM) reflect that distinction.
Where the evidence is strongest
Research published over the past decade supports melatonin for several specific conditions:
- Delayed sleep-wake phase disorder, in which a person’s natural sleep timing is shifted later than is workable for their life.
- Jet lag, particularly after eastward travel crossing multiple time zones.
- Non-24-hour sleep-wake disorder, most common in totally blind individuals whose circadian rhythm cannot be entrained by light.
- Shift work disorder, where it can help advance or delay sleep timing to match an unusual schedule.
- Sleep onset problems in children with autism or ADHD, where small randomized trials have shown modest benefits under medical supervision.
For garden-variety insomnia in healthy adults, by contrast, both the AASM and the American College of Physicians decline to recommend melatonin as a first-line treatment, citing limited evidence of benefit beyond placebo for chronic insomnia.
The dose problem
One of the most consistent themes in melatonin research is that more is not better, and is often worse. Studies of circadian phase shifting have repeatedly shown that very low doses — typically 0.3 to 0.5 milligrams — produce the same or greater clock-shifting effects than the 3, 5, or 10 milligram doses that dominate store shelves. Higher doses can produce serum melatonin levels that exceed natural nighttime peaks by 10 to 50 times, which may persist into the next morning and contribute to grogginess.
A widely cited study from Massachusetts Institute of Technology researchers, including Richard Wurtman, found that a 0.3 mg dose restored sleep in older adults more effectively than higher doses, with fewer side effects. More recent work summarized by the National Center for Biotechnology Information reaches similar conclusions for the chronobiotic effect.
Despite this, gummies and tablets containing 3 to 10 milligrams remain the norm, and some products advertise doses as high as 60 milligrams.
Why label doses cannot be trusted
The supplement quality picture is sobering. A 2023 analysis in JAMA tested 25 brands of melatonin gummies. The actual melatonin content ranged from 74% to 347% of the amount listed on the label. One product contained no detectable melatonin at all; another contained more than three times its labeled amount. A separate analysis of liquid and tablet formulations published in the Journal of Clinical Sleep Medicine in 2017 found similar variability and detected serotonin contamination in several products.
Because melatonin is regulated as a dietary supplement in the United States rather than a medication, manufacturers are not required to verify potency or purity before sale. Third-party verification programs such as USP, NSF, or ConsumerLab provide a more reliable signal that what is on the label matches what is in the bottle.
Children and the pediatric overdose surge
Pediatric melatonin use deserves particular caution. A 2022 report from the U.S. Centers for Disease Control and Prevention documented a 530% increase in pediatric melatonin ingestions reported to poison control centers between 2012 and 2021, with more than 260,000 cases over the decade. The vast majority involved unsupervised ingestion of gummies that children mistook for candy.
The American Academy of Sleep Medicine issued a 2022 health advisory urging parents to consult a pediatrician before using melatonin for children and to treat the supplement with the same caution as any medication. Behavioral sleep strategies — consistent bedtime, screen limits, a cool dark room, and predictable wind-down routines — remain the first-line approach for most childhood sleep difficulties.
Safety in adults
Short-term use of melatonin at appropriate doses is generally considered low-risk in healthy adults. Reported side effects include morning grogginess, vivid dreams, headache, dizziness, and mild gastrointestinal upset. Most resolve when the dose is lowered or the supplement is discontinued.
Several groups should be more cautious:
- People taking blood thinners, immunosuppressants, blood pressure medications, or diabetes medications, due to potential interactions.
- People with autoimmune conditions, given melatonin’s effects on immune signaling.
- Pregnant or breastfeeding individuals, where long-term safety data are limited.
- Older adults, who are more sensitive to next-day grogginess and falls.
Long-term safety data — beyond about six months of continuous use — remain sparse, which is another reason researchers favor the lowest effective dose for the shortest necessary duration.
A research-aligned approach
For adults considering melatonin for a circadian issue or jet lag, the evidence suggests:
- Start with the lowest available dose, typically 0.3 to 1 mg, rather than 3 to 10 mg.
- Take it 30 to 60 minutes before the desired sleep onset, not at the moment of attempting to fall asleep.
- Prefer products with third-party verification (USP, NSF, or ConsumerLab seals).
- Use it for a defined purpose and duration, not as an indefinite nightly habit.
- Keep all melatonin products out of reach of children, ideally in a locked cabinet.
For chronic insomnia, current guidelines favor cognitive behavioral therapy for insomnia (CBT-I) over any pharmacologic or supplement-based approach, including melatonin.
The bottom line
Melatonin is neither the harmless natural sleep aid that marketing often implies nor the dangerous hormone occasionally portrayed in headlines. It is a real biological signal with a narrow, evidence-based set of uses, often prescribed at doses far higher than the science supports and sold in products of inconsistent quality. Used thoughtfully — low dose, the right timing, a verified product, and a clear reason — it can be a useful tool. Used reflexively, in large doses, every night, it is mostly an expensive way to feel groggy in the morning.
Anyone with persistent sleep difficulties, unusual sleep timing, or who is considering melatonin for a child should consult a qualified healthcare provider rather than self-treating with over-the-counter products.
Disclosure: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.